Until cures are found, drug therapies are a lifeline to someone with cancer. Yet, the Life Raft Group’s GIST Patient Registry has recorded over 800 reports of patients interrupting their drug therapy usage because [...]
Autumn is here, ushering in the flu season. The flu can be a difficult illness for everyone, but for cancer patients, it can be devastating. Each year, millions of people contract the flu, hundreds [...]
The Life Raft Group completed the 2016 GIST Day of Learning series in St. Louis on October 8, 2016 at Siteman Cancer Center, Washington University in St. Louis. A huge thank you goes out [...]
On February 1, 2016, the commercial launch of the generic version of imatinib mesylate (Gleevec), originally for CML (Chronic Myeloid Leukemia), was approved by the FDA and became available for the first time in the United States through Sun Pharmaceuticals. In response to this transition, the LRG provided an educational Webinar to the CML and GIST communities on March 18th entitled “Generic Imatinib: Gaining Perspective.”
An article in Wayne Patch, a community-specific news, information and engagement network, features Life Fest 2014, The Life Raft Group’s biennial convention which was held on November 7-9 in Teaneck, New Jersey. In the article, [...]
The Bergen Record recently featured photographs of the LRG’s Life Fest Convention. Over 100,000 origami boats were made from around the globe to bring awareness to a rare form of intestinal cancer called gastrointestinal [...]
With the beautiful mountains of Switzerland and Lake Zurich in the background, 44 GIST Patient representatives from 28 countries and 32 patient groups/organizations convened in Zurich for the New Horizons GIST meeting from May 14-17, 2014.
The second annual GIST Day of Learning will be held on March 23, 2013. This year we are privileged once again that Dr. Jonathan Trent of Sylvester Cancer Center in Miami has agreed to host our gathering and we are honored to hear what he has to say.